Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by MML Investors Services LLC

MML Investors Services LLC cut its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 5.1% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 18,636 shares of the company’s stock after selling 1,007 shares during the period. MML Investors Services LLC’s holdings in Privia Health Group were worth $339,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Pier Capital LLC lifted its stake in Privia Health Group by 27.8% in the 3rd quarter. Pier Capital LLC now owns 389,895 shares of the company’s stock valued at $7,100,000 after buying an additional 84,786 shares in the last quarter. XTX Topco Ltd purchased a new position in shares of Privia Health Group in the third quarter valued at approximately $182,000. Soros Fund Management LLC lifted its position in shares of Privia Health Group by 25.0% in the third quarter. Soros Fund Management LLC now owns 750,000 shares of the company’s stock valued at $13,658,000 after acquiring an additional 150,000 shares in the last quarter. Quarry LP boosted its stake in shares of Privia Health Group by 344.6% in the third quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after acquiring an additional 2,533 shares during the last quarter. Finally, Centiva Capital LP increased its position in shares of Privia Health Group by 102.6% during the third quarter. Centiva Capital LP now owns 41,614 shares of the company’s stock worth $758,000 after purchasing an additional 21,073 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Stock Down 0.1 %

Shares of NASDAQ PRVA opened at $19.90 on Wednesday. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $24.30. The business’s 50 day moving average is $20.35 and its two-hundred day moving average is $19.17. The firm has a market cap of $2.39 billion, a price-to-earnings ratio of 199.02, a PEG ratio of 5.45 and a beta of 0.83.

Analyst Ratings Changes

A number of equities research analysts have recently commented on PRVA shares. JPMorgan Chase & Co. increased their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. KeyCorp assumed coverage on Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 target price on the stock. Truist Financial lifted their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Barclays raised their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Finally, Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $24.80.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.